Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane L Seger

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of the American Medical Informatics Association : JAMIA|October 27, 2015
Provider variation in responses to warnings: do the same providers run stop signs repeatedly?Patrick E Beeler, E John Orav, Diane L Seger, et al.
Journal of the American Medical Informatics Association : JAMIA|January 31, 2021
Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alertsSonam N Shah, Mary G Amato, Katherine G Garlo, et al.
JAMA Network Open|January 16, 2019
Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney DiseaseKatherine G Garlo, David W Bates, Diane L Seger, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Weight-based pediatric prescribing in ambulatory settingMatvey B Palchuk, Diane L Seger, Elaine G Recklet, et al.
Pharmacoepidemiology and Drug Safety|January 18, 2005
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactionsD Tony Yu, Josh F Peterson, Diane L Seger, et al.
Medicine|December 6, 2019
Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney diseaseKatherine G Garlo, David W Bates, Diane L Seger, et al.
Journal of General Internal Medicine|May 17, 2018
Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health RecordAdam Wright, Skye Aaron, Diane L Seger, et al.
Drug Safety|February 22, 2021
Comparison of Medication Alerts from Two Commercial Applications in the USASonam N Shah, Diane L Seger, Julie M Fiskio, et al.
Studies in Health Technology and Informatics|August 8, 2013
Understanding responses to a renal dosing decision support system in primary careInsook Cho, Sarah P Slight, Karen C Nanji, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosisAnn-Marcia C Tukpah, Jonathan A Rose, Diane L Seger, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of the American Medical Informatics Association : JAMIA|October 27, 2015
Provider variation in responses to warnings: do the same providers run stop signs repeatedly?Patrick E Beeler, E John Orav, Diane L Seger, et al.
Journal of the American Medical Informatics Association : JAMIA|January 31, 2021
Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alertsSonam N Shah, Mary G Amato, Katherine G Garlo, et al.
JAMA Network Open|January 16, 2019
Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney DiseaseKatherine G Garlo, David W Bates, Diane L Seger, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Weight-based pediatric prescribing in ambulatory settingMatvey B Palchuk, Diane L Seger, Elaine G Recklet, et al.
Pharmacoepidemiology and Drug Safety|January 18, 2005
Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactionsD Tony Yu, Josh F Peterson, Diane L Seger, et al.
Medicine|December 6, 2019
Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney diseaseKatherine G Garlo, David W Bates, Diane L Seger, et al.
Journal of General Internal Medicine|May 17, 2018
Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health RecordAdam Wright, Skye Aaron, Diane L Seger, et al.
Drug Safety|February 22, 2021
Comparison of Medication Alerts from Two Commercial Applications in the USASonam N Shah, Diane L Seger, Julie M Fiskio, et al.
Studies in Health Technology and Informatics|August 8, 2013
Understanding responses to a renal dosing decision support system in primary careInsook Cho, Sarah P Slight, Karen C Nanji, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Racial and ethnic associations with interstitial lung disease and healthcare utilization in patients with systemic sclerosisAnn-Marcia C Tukpah, Jonathan A Rose, Diane L Seger, et al.
Pageof 9